3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Melanoma
43
Colorectal Neoplasms
8
Uveal Melanoma
5
Carcinoma, Renal Cell
5
Carcinoma, Non-Small-Cell Lung
5
Brain Neoplasms
5
Stomach Neoplasms
4
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Lung Neoplasms
3
Carcinoma, Merkel Cell
3
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Pancreatic Neoplasms
2
Glioblastoma
2
Carcinoma, Hepatocellular
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Parotid Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Interventions
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
Bevacizumab
×
Dermatologic
×
Clear all
NCT06448364
2024-11-06
LTbR
Pfizer
Phase 1
Terminated
4 enrolled